The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Schneier, F. R.
* Articles by Laruelle, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Schneier, F. R.
* Articles by Laruelle, M.
Related Collections
* Neurotransmitters
* Phobic Disorders
Am J Psychiatry 157:457-459, March 2000
© 2000 American Psychiatric Association


Brief Report

Low Dopamine D2 Receptor Binding Potential in Social Phobia

Franklin R. Schneier, M.D., Michael R. Liebowitz, M.D., Anissa Abi-Dargham, M.D., Yolanda Zea-Ponce, Ph.D., Shu-Hsing Lin, Ph.D., and Marc Laruelle, M.D.

OBJECTIVE: This study compared dopamine D2 receptor binding potential in patients with social phobia and healthy comparison subjects. METHOD: Dopamine D2 receptor binding potential was assessed in 10 unmedicated subjects with generalized social phobia and no significant lifetime psychiatric comorbidity and 10 healthy comparison subjects matched for age and sex. Binding potential was measured in the striatum by using single photon emission computerized tomography and constant infusion of the D2 receptor radiotracer [123I]iodobenzamide ([123I]IBZM). RESULTS: Mean D2 receptor binding potential was significantly lower in the subjects with social phobia than in the comparison subjects. Within the social phobia group, there was a nonsignificant correlation of binding potential with the Liebowitz Social Anxiety Scale score. CONCLUSIONS: Generalized social phobia may be associated with low binding of [123I]IBZM to D2 receptors in the striatum.




This article has been cited by other articles:


Home page
JNMHome page
N. J. van der Wee, J. F. van Veen, H. Stevens, I. M. van Vliet, P. P. van Rijk, and H. G. Westenberg
Increased Serotonin and Dopamine Transporter Binding in Psychotropic Medication-Naive Patients with Generalized Social Anxiety Disorder Shown by 123I-{beta}-(4-Iodophenyl)-Tropane SPECT
J. Nucl. Med., May 1, 2008; 49(5): 757 - 763.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
B. W. Dunlop and C. B. Nemeroff
The Role of Dopamine in the Pathophysiology of Depression
Arch Gen Psychiatry, March 1, 2007; 64(3): 327 - 337.
[Full Text] [PDF]


Home page
ScienceHome page
O. Berton, C. A. McClung, R. J. DiLeone, V. Krishnan, W. Renthal, S. J. Russo, D. Graham, N. M. Tsankova, C. A. Bolanos, M. Rios, et al.
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
Science, February 10, 2006; 311(5762): 864 - 868.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
M. R. Liebowitz, A. J. Gelenberg, and D. Munjack
Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Arch Gen Psychiatry, February 1, 2005; 62(2): 190 - 198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. Laakso, E. Wallius, J. Kajander, J. Bergman, O. Eskola, O. Solin, T. Ilonen, R. K.R. Salokangas, E. Syvalahti, and J. Hietala
Personality Traits and Striatal Dopamine Synthesis Capacity in Healthy Subjects
Am J Psychiatry, May 1, 2003; 160(5): 904 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. J. Aragona, Y. Liu, J. T. Curtis, F. K. Stephan, and Z. Wang
A Critical Role for Nucleus Accumbens Dopamine in Partner-Preference Formation in Male Prairie Voles
J. Neurosci., April 15, 2003; 23(8): 3483 - 3490.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. ANAND and A. SHEKHAR
Brain Imaging Studies in Mood and Anxiety Disorders: Special Emphasis on the Amygdala
Ann. N.Y. Acad. Sci., April 1, 2003; 985(1): 370 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. CAMACHO and M. B. STEIN
Modafinil for Social Phobia and Amphetamine Dependence
Am J Psychiatry, November 1, 2002; 159(11): 1947 - 1948.
[Full Text]


Home page
Arch Gen PsychiatryHome page
M. B. Stein, P. R. Goldin, J. Sareen, L. T. E. Zorrilla, and G. G. Brown
Increased Amygdala Activation to Angry and Contemptuous Faces in Generalized Social Phobia
Arch Gen Psychiatry, November 1, 2002; 59(11): 1027 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
B. A. Racette, J. M. Hartlein, T. Hershey, J. W. Mink, J. S. Perlmutter, and K. J. Black
Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2002; 14(4): 438 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
S. J. Mathew, J. D. Coplan, and J. M. Gorman
Neurobiological Mechanisms of Social Anxiety Disorder
Am J Psychiatry, October 1, 2001; 158(10): 1558 - 1567.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
F. R. SCHNEIER, M. R. LIEBOWITZ, and M. LARUELLE
Detachment and Generalized Social Phobia
Am J Psychiatry, February 1, 2001; 158(2): 327- - 327.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org